Amag Pharmaceuticals, Inc.
Clinical trials sponsored by Amag Pharmaceuticals, Inc., explained in plain language.
-
Promising preeclampsia drug trial halted early – what happened?
Disease control TerminatedThis study tested an experimental drug called AMAG-423 (Digoxin Immune Fab) in pregnant women with severe preeclampsia, a dangerous condition of high blood pressure during pregnancy. The goal was to see if the drug could reduce serious health problems in babies, such as bleeding …
Phase: PHASE2, PHASE3 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Experimental antidote for blood thinners tested in early trial
Disease control TerminatedThis phase 2 trial tested a drug called ciraparantag to see if it could quickly reverse the effects of blood thinners in 41 healthy adults. Participants received either ciraparantag or a placebo, and their blood clotting time was measured. The study was terminated early, so the f…
Phase: PHASE2 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC